Section 1 Adding standards for drug compendia for physician use for purposes of payment under Medicaid for certain drugs
In general— Section 1927(g)(1)(B)(i) of the Social Security Act (42 U.S.C. 1396r–8(g)(1)(B)(i)) is amended—
in subclause (I), by striking the semicolon at the end and inserting a period;
in subclause (II), by striking “); and” at the end and inserting “).”;
in subclause (III)—
by striking “the DRUGDEX” and inserting “The DRUGDEX”; and
by striking “; and” at the end and inserting a period; and
by adding at the end the following:
“(IV) Other compendia that, as determined by the Secretary—
“(aa) are utilized nationwide by the private health insurance industry;
“(bb) are used by health care providers, such as long-term care facilities or academic health centers;
“(cc) have a publicly available policy on the disclosure of conflicts of interest that may exist between such a health care provider and drug manufacturers;
“(dd) use an international, widely recognized standard to systematically evaluate the clinical evidence for inclusion in the compendia; and
“(ee) are accepted as professional drug compendia by at least one State board of pharmacy (or an equivalent State licensing body).”
Technical amendments— Section 1927(g)(1)(B) of the Social Security Act (42 U.S.C. 1396r–8(g)(1)(B)) is amended—
in clause (i), by striking “compendia” and inserting “Compendia”; and
in clause (ii), by striking “the peer-reviewed” and inserting “The peer-reviewed”.